Facultad de Medicina (FM)
Centro académico
Maastricht University Medical Centre
Maastricht, HolandaPublicacions en col·laboració amb investigadors/es de Maastricht University Medical Centre (35)
2024
-
A new framework for the diagnosis, staging and management of obesity in adults
Nature Medicine
-
Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial
Hypertension Research
-
Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI)
Pediatric Research
-
Hyperbilirubinemia and retinopathy of prematurity: a retrospective cohort study
European Journal of Pediatrics, Vol. 183, Núm. 9, pp. 3809-3818
-
Stroke in critically ill patients with respiratory failure due to COVID-19: Disparities between low-middle and high-income countries
Heart and Lung, Vol. 68, pp. 131-144
-
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial
Heart, Vol. 110, Núm. 19, pp. 1180-1187
2023
-
Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study
Cerebrovascular Diseases Extra, Vol. 13, Núm. 1, pp. 18-32
-
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)
Cancers, Vol. 15, Núm. 4
-
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331
-
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months after a Diagnosis of COVID-19
Transplantation, Vol. 106, Núm. 5, pp. 1012-1023
-
Current Evolutions in Axillary Management
Breast Care
-
Endothelial dysfunction in preterm infants: The hidden legacy of uteroplacental pathologies
Frontiers in Pediatrics, Vol. 10
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
2021
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Variations in antibiotic use and sepsis management in neonatal intensive care units: A european survey
Antibiotics, Vol. 10, Núm. 9
2020
-
COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration
Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983
2019
-
The ABCD of obesity: An EASO position statement on a diagnostic term with clinical and scientific implications
Obesity Facts, Vol. 12, Núm. 2, pp. 131-136